The precise and meticulous Cochran devised a new mathematical insight to judge the trials. Rather than privilege any particular study, he reasoned, perhaps one could use a method to estimate the relative risk as a composite number through all trials in the aggregate. (This method, termed meta-analysis, would deeply influence academic epidemiology in the future.)
